Zoetis
5 Giralda Farms
Madison
New Jersey
07940
United States
Tel: 973660-7491
Website: http://www.zoetis.com/
223 articles about Zoetis
-
Zoetis to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
9/9/2022
Zoetis Inc. (NYSE:ZTS) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022.
-
Zoetis Announces Second Quarter 2022 Results
8/4/2022
Zoetis Inc. reported its financial results for the second quarter of 2022 and updated its guidance for full year 2022 to reflect its positive outlook for the remainder of the year, as well as the negative impact of recent changes to foreign exchange rates.
-
Zoetis Appoints Vanessa Broadhurst to its Board of Directors
7/25/2022
Zoetis Inc. (NYSE: ZTS) today announced the appointment of Vanessa Broadhurst, Executive Vice President, Global Corporate Affairs at Johnson & Johnson, to its Board of Directors.
-
Zoetis to Host Webcast and Conference Call on Second Quarter 2022 Financial Results
6/30/2022
Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 4, 2022.
-
Zoetis to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
6/10/2022
Zoetis to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference.
-
Zoetis Announces First Quarter 2022 Results
5/5/2022
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2022 and updated its guidance for full year 2022 due to the negative impact of recent changes in foreign exchange rates.
-
Zoetis to Host Webcast and Conference Call on First Quarter 2022 Financial Results
3/31/2022
Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 5, 2022.
-
Zoetis Declares Second Quarter 2022 Dividend
2/8/2022
The Board of Directors of Zoetis Inc. has declared a dividend of $0.325 per share for the second quarter of 2022.
-
Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Osteoarthritis Pain in Cats
1/13/2022
Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Solensia™ to control the pain of osteoarthritis (OA) in cats, helping improve their mobility, comfort and overall well-being.
-
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2021 Financial Results
12/23/2021
Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 15, 2022.
-
Zoetis Announces Authorization of $3.5 Billion Share Repurchase Program
12/7/2021
Zoetis Inc. announced that its Board of Directors has approved a $3.5 billion share repurchase program as part of its capital allocation plans.
-
Zoetis Announces Third Quarter 2021 Results
11/4/2021
Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2021 and increased its guidance for full year 2021.
-
Zoetis Announces Appointment of Robert J. Polzer, PhD, as President of Research & Development for World Leader in Animal Health
10/18/2021
Zoetis Inc. (NYSE:ZTS) today announced the appointment of Robert J. Polzer, PhD, as Executive Vice President and President of Research & Development for the company, effective Jan. 1, 2022.
-
Zoetis to Host Webcast and Conference Call on Third Quarter 2021 Financial Results
9/30/2021
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 4, 2021. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review third quarter 2021 financial results and respond to questions from financial analysts during the call.
-
Zoetis Announces Second Quarter 2021 Results
8/5/2021
Reports Revenue of $1.9 Billion, Growing 26%, and Net Income of $512 Million, or $1.07 per Diluted Share, Increasing 36% and 35%, Respectively, on a Reported Basis for Second Quarter 2021
-
Zoetis to Acquire Jurox, a Leading Provider and Manufacturer of Livestock and Companion Animal Products
8/4/2021
Zoetis Inc. (NYSE: ZTS) today announced it has entered into an agreement to acquire Jurox, a privately held animal health company, which develops, manufactures and markets a wide range of veterinary medicines for treating companion animals and livestock.
-
Zoetis to Host Webcast and Conference Call on Second Quarter 2021 Financial Results
6/30/2021
Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Aug. 5, 2021.
-
Zoetis A.L.P.H.A. Initiative Improves Livestock Health and Farmers’ Livelihoods in Sub-Saharan Africa with 1.7 billion Doses of Vaccines and Medicines administered in Four Years
6/10/2021
Livestock health and farmers’ livelihoods have been dramatically improved in Sub-Saharan Africa, following the administration of 1.7 billion doses of vaccines and medicines and over 650,000 diagnostic tests through Zoetis’ African Livestock Productivity and Health Advancement initiative, now in its fourth year.
-
Zoetis Adds Devices for Use in Regenerative Medicine Therapies to its Growing Equine Portfolio
6/1/2021
The range of products are designed to help veterinarians address common - and sometimes debilitating - injuries in horses
-
Zoetis to Participate in the Stifel 2021 Virtual Jaws & Paws Conference
5/24/2021
Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2021 Virtual Jaws & Paws Conference on Thursday, June 3, 2021. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts.